Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.520
-0.030 (-1.94%)
Sep 12, 2025, 4:00 PM EDT - Market closed

Acrivon Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
48187109241--
Market Cap Growth
-79.16%71.66%-54.61%---
Enterprise Value
-864-28291--
Last Close Price
1.526.024.9211.52--
PB Ratio
0.331.060.901.41--
P/TBV Ratio
0.331.060.901.41--
Debt / Equity Ratio
0.020.020.040.030.060.04
Quick Ratio
10.2310.439.5819.6134.182.58
Current Ratio
10.3110.559.7520.2734.462.80
Return on Equity (ROE)
-47.88%-54.07%-41.41%-23.16%-32.40%-
Return on Assets (ROA)
-30.32%-33.30%-26.25%-14.18%-18.60%-
Return on Capital (ROIC)
-32.19%-36.41%-27.84%-14.59%-19.09%-
Earnings Yield
-179.78%-42.98%-55.30%-12.95%--
FCF Yield
-153.09%-36.51%-40.23%-13.42%--
Buyback Yield / Dilution
-48.59%-53.05%-435.63%-136.43%-21.70%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q